From the San Antonio Breast Conference in December, new data shows a higher than predicted rate of breast cancer recurrence even with very small breast cancers that are HER2 positive. The data is from the first large study to analyze early-stage breast cancer patients with HER2 positive tumors one centimeter or smaller. All these women would benefit from adjuvant Trastuzumab, also known as Herceptin, (for one year, the standard in America) - along with adjuvant chemotherapy. This represents a...

Eight Breast Cancer Symptoms: When To Worry
Ten Breast Cancer Myths Debunked
Eat to Live: 10 Things to Know About Breast Cancer and Nutrition
When Breast Cancer Returns: 10 Things to Know About Metastatic Breast Cancer 